Table 1 Demographics and clinical characteristics in the escitalopram cohort.
Total (n = 125) | Responders (n = 56) | Non-responders (n = 69) | Test of difference | |||||
|---|---|---|---|---|---|---|---|---|
Variable | n | (%) | n | (%) | n | (%) | X2 | P |
Female | 78 | 62.4 | 37 | 66.1 | 41 | 59.4 | 0.583 | 0.445 |
Mean | SD | Mean | SD | Mean | SD | t | P | |
Age | 36.4 | 13.0 | 36.1 | 13.2 | 36.7 | 12.8 | −0.247 | 0.806 |
MADRS Week 0 | 30.0 | 5.8 | 29.4 | 5.8 | 30.5 | 5.8 | −1.050 | 0.296 |
MADRS Week 2 | 23.3 | 8.5 | 20.2 | 8.4 | 25.8 | 7.8 | −3.848 | <0.001 |
MADRS Week 8 | 16.8 | 10.5 | 7.8 | 5.0 | 24.2 | 7.6 | −13.780 | <0.001 |
% Change in MADRS | 44.2 | 32.7 | 73.5 | 16.0 | 20.5 | 21.5 | 15.290 | <0.001 |
